Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: A study of 106 cases

被引:153
作者
Reilly, JT
Snowden, JA
Spearing, RL
Fitzgerald, PM
Jones, N
Watmore, A
Potter, A
机构
[1] ROYAL HALLAMSHIRE HOSP,DEPT MOL HAEMATOL,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND
[2] CHRISTCHURCH HOSP,DEPT HAEMATOL,CHRISTCHURCH,NEW ZEALAND
[3] CHRISTCHURCH HOSP,DEPT CYTOGENET,CHRISTCHURCH,NEW ZEALAND
[4] UNIV SHEFFIELD,STAT SERV UNIT,SHEFFIELD S10 2TN,S YORKSHIRE,ENGLAND
[5] CTR HUMAN GENET,SHEFFIELD,S YORKSHIRE,ENGLAND
关键词
myelofibrosis; cytogenetics; prognostic factors;
D O I
10.1046/j.1365-2141.1997.1722990.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The prognostic significance of cytogenetic abnormalities was determined in 106 patients with well-characterized idiopathic myelofibrosis who were successfully karyotyped at diagnosis. 35% of the cases exhibited a clonal abnormality (37/100), whereas 65% (69/106) had a normal karyotype. Three characteristic defects, namely del(13q) (nine cases), del(20q) (eight cases) and partial trisony 1q (seven cases), were present in 64.8% (24/37) of patients with clonal abnormalities. Kaplan-Meier plots and log rank analysis demonstrated an abnormal karyotype to be an adverse prognostic variable (P< 0.001), Of the eight additional clinical and haematological parameters recorded at diagnosis, age (P < 0.01), anaemia (haemoglobin less than or equal to 10 g/dl; P<0.001), platelet (less than or equal to 100x10(9)/l. P<0.0001) and leucocyte count (>10.3x10(9)/l; P=0.06) were also associated with a shorter survival. In contrast, sex, spleen and liver size, and percentage blast cells were not found to he significant, Multivariate analysis, using Cox's regression, revealed karyotype, haemoglobin concentration, platelet and leucocyte counts to retain their unfavourable prognostic significance, A simple and useful schema for predicting survival in idiopathic myelofibrosis has been produced by combining age, haemoglobin concentration and karyotype with median survival times varying from 180 months (good-risk group) to 16 months (poor-risk group).
引用
收藏
页码:96 / 102
页数:7
相关论文
共 39 条
[1]  
[Anonymous], CHROMOSOMES HUMAN CA
[2]  
Asimakopoulos FA, 1996, BRIT J HAEMATOL, V95, P219
[3]   A PROGNOSTIC CLASSIFICATION OF MYELOFIBROSIS WITH MYELOID METAPLASIA [J].
BAROSI, G ;
BERZUINI, C ;
LIBERATO, LN ;
COSTA, A ;
POLINO, G ;
ASCARI, E .
BRITISH JOURNAL OF HAEMATOLOGY, 1988, 70 (04) :397-401
[4]  
BESA EC, 1982, CANCER, V49, P308, DOI 10.1002/1097-0142(19820115)49:2<308::AID-CNCR2820490217>3.0.CO
[5]  
2-4
[6]  
BORGSTROM GH, 1984, SCAND J HAEMATOL, V33, P15
[7]   EVIDENCE FOR A NEW TUMOR SUPPRESSOR LOCUS (DBM) IN HUMAN B-CELL NEOPLASIA TELOMERIC TO THE RETINOBLASTOMA GENE [J].
BROWN, AG ;
ROSS, FM ;
DUNNE, EM ;
STEEL, CM ;
WEIRTHOMPSON, EM .
NATURE GENETICS, 1993, 3 (01) :67-72
[8]  
CHELLOUL N, 1976, BIOMEDICINE, V24, P272
[9]  
COX DR, 1972, J R STAT SOC B, V34, P187
[10]  
DEMORY JL, 1988, BLOOD, V72, P855